Medical Marijuana and the Opioid Crisis: Can It Have an Impact?

Medical Marijuana and the Opioid Crisis: Can It Have an Impact?

Publication date: Jan 13, 2020

Dublin, Jan. 13, 2020 (GLOBE NEWSWIRE) — The “Medical Marijuana and the Opioid Crisis” report has been added to ResearchAndMarkets. com’s offering.

Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes.

List of Tables Table 1: Examples of Companies Manufacturing Medical Marijuana Table 2: Examples of Companies Working on Cannabinoids in Drug Development List of Figures Figure 1: THC and Its Effect on the Endocannabinoid System Figure 2: Effect of Opioid on Pain Relief in the Nervous System Figure 3: Statistics for Opioid-Related Deaths, 1999-2017 Figure 4: Total Number of Publications Related to Marijuana and Pain, 2012-2018 For more information about this report visit ResearchAndMarkets. com ResearchAndMarkets. com is the world’s leading source for international market research reports and market data.

Concepts Keywords
California Cannabis
Cannabis Appetite stimulants
Cannabis Plant Herbalism
Dublin Medicine
Guam Medicinal plants
Marijuana Illegal federal law
Market Data Federal law example
Opioid Entheogens
Opioid Addiction Euphoriants
Opioids Psychoactive drugs
Painkiller Medical cannabis
Proposition 215 Tetrahydrocannabinol
Psychoactive Drug Effects of cannabis
Puerto Rico
Recreational Drug
Substitute
THC
Virgin Islands

Semantics

Type Source Name
disease MESH Development
disease MESH opioid addiction
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Coenzyme M
drug DRUGBANK Medical Cannabis

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *